Proposed approval of the new active constituent, cefquinome sulphate, and registration of Cobactan IV

This consultation closed on 7 April 2015.
Consultation period: 
10 March 2015 to 7 April 2015

The APVMA is considering an application for the registration of the product Cobactan IV. The product is to be used for the treatment of bacterial respiratory infections in adult horses.

We invite comment from 10 March 2015 to 7 April 2015 on whether the application for approval of the active constituent and registration of the product should be granted.

For more information, APVMA Gazette Notice (page 29) from 10 March 2015.

Please send your written submission by email, post or fax to:

Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Email: enquiries@apvma.gov.au
Fax: +61 2 6210 4741

For enquiries, please call +61 2 6210 4701. 

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.